Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRNX Crinetics Pharmaceuticals Inc.

交易中 04-22 15:58:09 EDT

31.26

+1.11

+3.68%

最高31.30	最低30.45	成交量42.45万
今开30.68	昨收30.15	日振幅2.82%
总市值29.09亿	流通市值28.65亿	总股本9,305万
成交额1,314万	换手率0.46%	流通股本9,164万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":31.26,"timestamp":1745351886623,"preClose":30.15,"halted":0,"volume":424498,"delay":0,"floatShares":91642509,"shares":93048538,"eps":-3.693945,"marketStatus":"交易中","change":1.11,"latestTime":"04-22 15:58:09 EDT","open":30.68,"high":31.3,"low":30.45,"amount":13135702.618827999,"amplitude":0.028192,"askPrice":31.27,"askSize":150,"bidPrice":31.25,"bidSize":760,"shortable":3,"etf":0,"ttmEps":-3.693945,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1531886400000,"exchange":"NASDAQ","adjPreClose":30.15,"preHourTrading":{"tag":"盘前","latestPrice":30.66,"preClose":30.15,"latestTime":"09:29 EDT","volume":127,"amount":3889.299435,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":30.15,"preClose":30.15,"latestTime":"16:52 EDT","volume":19211,"amount":579197.25,"timestamp":1745268756325},"volumeRatio":0.621448,"impliedVol":0.4127,"impliedVolPercentile":0.152},"requestUrl":"/m/hq/s/CRNX","defaultTab":"news","newsList":[{"id":"2517589074","title":"Crinetics Pharmaceuticals, Inc.2024财年实现净利润-2.98亿美元，同比减少38.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517589074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517589074?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363257,"startTime":"0","endTime":"0","summary":"3月8日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-2.98亿美元，同比减少38.60%；其中营业收入为1.04百万美元，同比减少74.06%，每股基本收益为-3.69美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债4.01亿美元，其中短期债务7.15百万美元，资产负债比为4.31，流动比率为0.24。机构评级：截至2025年3月8日，当前有14家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为75.64美元，其中最低目标价为55.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2514904376","title":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904376","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514904376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRNX"],"gpt_icon":0},{"id":"1171905954","title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1171905954","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171905954?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:22","pubTimestamp":1740756147,"startTime":"0","endTime":"0","summary":"Crinetics制药公司今日盘中大涨5.09%,引发了市场的广泛关注。\n公司日前公布的最新季度业绩显示,2024年第四季度,公司调整后每股亏损为88美分,同比收窄2美分,略好于分析师预期的89美分亏损。尽管如此,公司当季实际亏损8060万美元,同比加大。\n不过,公司当季度业绩整体表现略好于预期,以及分析师看好其长期前景,推动了公司股价今日盘中出现较大涨幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRNX"],"gpt_icon":0},{"id":"1125291574","title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1125291574","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125291574?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:24","pubTimestamp":1740691484,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals  公布季度每股亏损 $，与分析师一致预期相符。这比去年同期每股亏损 $ 增加了 2.22%。以上内容来自Benzinga Earnings专栏，原文如下：Crinetics Pharmaceuticals  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 2.22 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"gpt_icon":0},{"id":"2514013011","title":"Crinetics Pharmaceuticals, Inc.盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013011?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:04","pubTimestamp":1740495849,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.14%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230409962ffa35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230409962ffa35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2514723677","title":"Crinetics Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.03%报35.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514723677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514723677?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:14","pubTimestamp":1740420878,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时14分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.03%。截至发稿，该股报35.58美元/股，成交量50.7495万股，换手率0.55%，振幅5.57%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021439abdb3f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021439abdb3f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2509602460","title":"Crinetics Pharmaceuticals(CRNX.US)获Wolfe Research首次覆盖，给予Peer Perform评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509602460","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509602460?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:19","pubTimestamp":1738693194,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals(CRNX.US)获Wolfe Research首次覆盖，给予Peer Perform评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05021947950296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRNX"],"gpt_icon":0},{"id":"2505269387","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505269387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505269387?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:33","pubTimestamp":1737556413,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时33分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.01%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为458.08%、92.78%、53.12%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc.、Genelux Corporation，振幅分别为24.62%、14.97%、14.89%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223333960cff7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223333960cff7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2503858680","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503858680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503858680?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:44","pubTimestamp":1736779491,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时44分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.10%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4248.09%、2452.14%、403.17%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Kairos Pharma, Ltd.，振幅分别为104.79%、102.87%、67.84%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244519864d88a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244519864d88a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","BK4139","CRNX","KAPA"],"gpt_icon":0},{"id":"2502867525","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867525?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519562,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.14%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为923.91%、138.86%、121.58%，振幅较大的相关个股有Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.，振幅分别为22.22%、18.90%、15.25%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022324395ff6d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022324395ff6d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139"],"gpt_icon":0},{"id":"2484130629","title":"Crinetics Pharmaceuticals, Inc.2024财年第三财季实现净利润-76.83百万美元，同比减少33.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484130629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484130629?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010425,"startTime":"0","endTime":"0","summary":"11月19日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-76.83百万美元，同比减少33.71%；其中营业收入为0.00美元，每股基本收益为-0.96美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债1.04亿美元，其中短期债务7.41百万美元，资产负债比为9.01，流动比率为0.17。机构评级：截至2024年11月19日，当前有13家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为74.77美元，其中最低目标价为55.00美元，最高目标价为97.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180135abcedf5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180135abcedf5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2475637498","title":"Crinetics Pharmaceuticals, Inc.盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475637498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475637498?lang=zh_cn&edition=full","pubTime":"2024-10-16 00:13","pubTimestamp":1729008811,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日00时13分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.08%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001331971a06d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001331971a06d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crinetics.com","stockEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":-0.1241},{"period":"3month","weight":-0.2221},{"period":"6month","weight":-0.4837},{"period":"1year","weight":-0.2983},{"period":"ytd","weight":-0.4103}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.100087},{"month":2,"riseRate":0.571429,"avgChangeRate":0.000642},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.048453},{"month":4,"riseRate":0.571429,"avgChangeRate":0.055026},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.006472},{"month":6,"riseRate":0.666667,"avgChangeRate":0.007507},{"month":7,"riseRate":0.5,"avgChangeRate":-0.028721},{"month":8,"riseRate":0.428571,"avgChangeRate":0.05139},{"month":9,"riseRate":0.285714,"avgChangeRate":0.070664},{"month":10,"riseRate":0.428571,"avgChangeRate":0.002208},{"month":11,"riseRate":0.857143,"avgChangeRate":0.113084},{"month":12,"riseRate":0.714286,"avgChangeRate":0.039066}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}